HRP20100272T2 - Piridinaminosulfonil supstituirani benzamidi kao inhibitori citokroma p450 3a4 (cyp3a4) - Google Patents
Piridinaminosulfonil supstituirani benzamidi kao inhibitori citokroma p450 3a4 (cyp3a4) Download PDFInfo
- Publication number
- HRP20100272T2 HRP20100272T2 HR20100272T HRP20100272T HRP20100272T2 HR P20100272 T2 HRP20100272 T2 HR P20100272T2 HR 20100272 T HR20100272 T HR 20100272T HR P20100272 T HRP20100272 T HR P20100272T HR P20100272 T2 HRP20100272 T2 HR P20100272T2
- Authority
- HR
- Croatia
- Prior art keywords
- cr12ar12b
- alkyl
- hydrogen
- amino
- sulfonyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/76—Nitrogen atoms to which a second hetero atom is attached
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US72015105P | 2005-09-23 | 2005-09-23 | |
| US72311505P | 2005-10-03 | 2005-10-03 | |
| US72546905P | 2005-10-11 | 2005-10-11 | |
| US76225606P | 2006-01-25 | 2006-01-25 | |
| US82166406P | 2006-08-07 | 2006-08-07 | |
| PCT/IB2006/002639 WO2007034312A2 (fr) | 2005-09-23 | 2006-09-11 | Composes therapeutiques |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HRP20100272T1 HRP20100272T1 (en) | 2010-06-30 |
| HRP20100272T2 true HRP20100272T2 (hr) | 2010-07-31 |
Family
ID=37889174
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20100272T HRP20100272T2 (hr) | 2005-09-23 | 2006-09-11 | Piridinaminosulfonil supstituirani benzamidi kao inhibitori citokroma p450 3a4 (cyp3a4) |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US7868026B2 (fr) |
| EP (1) | EP1937639B1 (fr) |
| JP (1) | JP4336738B2 (fr) |
| KR (1) | KR100975448B1 (fr) |
| CN (1) | CN101287708B (fr) |
| AT (1) | ATE459603T1 (fr) |
| AU (1) | AU2006293605B2 (fr) |
| BR (1) | BRPI0616156A2 (fr) |
| CA (1) | CA2621805C (fr) |
| CY (1) | CY1110010T1 (fr) |
| DE (1) | DE602006012713D1 (fr) |
| DK (1) | DK1937639T3 (fr) |
| EA (1) | EA014329B1 (fr) |
| EC (1) | ECSP088296A (fr) |
| ES (1) | ES2340200T3 (fr) |
| GE (1) | GEP20115230B (fr) |
| HR (1) | HRP20100272T2 (fr) |
| IL (1) | IL189666A (fr) |
| MA (1) | MA29791B1 (fr) |
| MY (1) | MY143391A (fr) |
| NO (1) | NO20081844L (fr) |
| NZ (1) | NZ566136A (fr) |
| PL (1) | PL1937639T3 (fr) |
| PT (1) | PT1937639E (fr) |
| RS (2) | RS20080118A (fr) |
| SI (1) | SI1937639T1 (fr) |
| TN (1) | TNSN08139A1 (fr) |
| WO (1) | WO2007034312A2 (fr) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2660031A1 (fr) * | 2006-07-05 | 2008-01-10 | Pfizer Products Inc. | Derives de pyrazole utilises en tant qu'inhibiteurs du cytochrome p450 |
| CA2673586A1 (fr) * | 2006-12-26 | 2008-07-24 | Amgen Inc. | N-cyclohexyl benzamides et benzene acetamides utilises comme inhibiteurs de 11-beta-hydroxysteroides deshydrogenases |
| WO2008112164A2 (fr) | 2007-03-08 | 2008-09-18 | The Board Of Trustees Of The Leland Stanford Junior University | Modulateurs de l'aldéhyde déshydrogénase-2 mitochondrial, et leurs procédés d'utilisation |
| KR101178674B1 (ko) * | 2007-10-04 | 2012-08-30 | 에프. 호프만-라 로슈 아게 | 사이클로프로필 아릴 아마이드 유도체 및 이의 용도 |
| WO2010028175A1 (fr) | 2008-09-08 | 2010-03-11 | The Board Of Trustees Of The Leland Stanford Junior University | Modulateurs de l'activité de l'aldéhyde déshydrogénase et leurs procédés d'utilisation |
| JP2012506856A (ja) | 2008-10-28 | 2012-03-22 | ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティ | アルデヒドデヒドロゲナーゼのモジュレーターおよびその使用方法 |
| CA2747419C (fr) | 2009-01-12 | 2014-07-08 | Icagen, Inc. | Derives sulfonamides |
| CN102427810A (zh) * | 2009-05-01 | 2012-04-25 | 拉夸里亚创药株式会社 | 作为trpm8拮抗剂的氨磺酰基苯甲酸衍生物 |
| JP5872552B2 (ja) | 2010-07-09 | 2016-03-01 | ファイザー・リミテッドＰｆｉｚｅｒ Ｌｉｍｉｔｅｄ | 化学化合物 |
| WO2012149106A1 (fr) | 2011-04-29 | 2012-11-01 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions et procédés d'augmentation de la prolifération de cellules souches salivaires adultes |
| WO2014000178A1 (fr) | 2012-06-27 | 2014-01-03 | Merck Sharp & Dohme Corp. | Dérivés de sulfamide et leurs méthodes d'utilisation permettant d'améliorer la pharmacocinétique d'un médicament |
| KR20150135332A (ko) | 2013-03-14 | 2015-12-02 | 더 보드 오브 트러스티스 오브 더 리랜드 스탠포드 쥬니어 유니버시티 | 미토콘드리아 알데히드 탈수소효소-2 조절인자들 및 이들의 사용 방법 |
| TW201512171A (zh) | 2013-04-19 | 2015-04-01 | Pfizer Ltd | 化學化合物 |
| WO2014194519A1 (fr) | 2013-06-07 | 2014-12-11 | Merck Sharp & Dohme Corp. | Dérivés imidazole et leurs procédés d'utilisation pour l'amélioration des propriétés pharmacocinétiques d'un médicament |
| WO2015070366A1 (fr) | 2013-11-12 | 2015-05-21 | Merck Sharp & Dohme Corp. | Dérivés d'imidazole et de triazole liés à aryle et leurs procédés d'utilisation pour améliorer la pharmacocinétique d'un médicament |
| WO2015070367A1 (fr) | 2013-11-12 | 2015-05-21 | Merck Sharp & Dohme Corp. | Dérivés d'imidazole et de triazole liés à la pipéridine ou la pipérazine et leurs procédés d'utilisation pour améliorer la pharmacocinétique d'un médicament |
| MA50635A (fr) | 2014-03-26 | 2020-08-12 | Hoffmann La Roche | Nouveaux composés bicycliques comme inhibiteurs de la production d'autotaxin (atx) et de l'acide lysophosphatidique |
| WO2016101118A1 (fr) * | 2014-12-23 | 2016-06-30 | Merck Sharp & Dohme Corp. | Antagonistes des récepteurs d'orexine de type amidoéthylazole |
| EP3344619B1 (fr) | 2015-09-04 | 2020-10-28 | H. Hoffnabb-La Roche Ag | Dérivés phénoxyméthyles |
| EP3596060B1 (fr) | 2017-03-16 | 2023-09-20 | F. Hoffmann-La Roche AG | Nouveaux composés bicycliques utilisés en tant qu'inhibiteurs d'atx |
| CN116903531B (zh) * | 2023-07-21 | 2025-12-12 | 上海中医药大学 | 细胞色素p450酶3a4的抑制剂及其制备方法与应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7169763B2 (en) | 2002-02-22 | 2007-01-30 | Oliver Yoa-Pu Hu | Cytochrome P450 3A inhibitors and enhancers |
-
2006
- 2006-09-11 GE GEAP200610575A patent/GEP20115230B/en unknown
- 2006-09-11 JP JP2008531812A patent/JP4336738B2/ja not_active Expired - Fee Related
- 2006-09-11 KR KR1020087006967A patent/KR100975448B1/ko not_active Expired - Fee Related
- 2006-09-11 SI SI200630666T patent/SI1937639T1/sl unknown
- 2006-09-11 CA CA2621805A patent/CA2621805C/fr not_active Expired - Fee Related
- 2006-09-11 AT AT06795544T patent/ATE459603T1/de active
- 2006-09-11 PL PL06795544T patent/PL1937639T3/pl unknown
- 2006-09-11 RS RSP-2008/0118A patent/RS20080118A/sr unknown
- 2006-09-11 HR HR20100272T patent/HRP20100272T2/hr unknown
- 2006-09-11 BR BRPI0616156-1A patent/BRPI0616156A2/pt not_active IP Right Cessation
- 2006-09-11 DE DE602006012713T patent/DE602006012713D1/de active Active
- 2006-09-11 AU AU2006293605A patent/AU2006293605B2/en not_active Ceased
- 2006-09-11 EP EP06795544A patent/EP1937639B1/fr active Active
- 2006-09-11 RS RSP-2010/0237A patent/RS51349B/sr unknown
- 2006-09-11 PT PT06795544T patent/PT1937639E/pt unknown
- 2006-09-11 WO PCT/IB2006/002639 patent/WO2007034312A2/fr not_active Ceased
- 2006-09-11 ES ES06795544T patent/ES2340200T3/es active Active
- 2006-09-11 CN CN2006800348278A patent/CN101287708B/zh not_active Expired - Fee Related
- 2006-09-11 DK DK06795544.3T patent/DK1937639T3/da active
- 2006-09-11 NZ NZ566136A patent/NZ566136A/en not_active IP Right Cessation
- 2006-09-11 EA EA200800542A patent/EA014329B1/ru not_active IP Right Cessation
-
2007
- 2007-01-09 US US11/621,410 patent/US7868026B2/en not_active Expired - Fee Related
-
2008
- 2008-02-21 IL IL189666A patent/IL189666A/en not_active IP Right Cessation
- 2008-03-19 TN TNP2008000139A patent/TNSN08139A1/fr unknown
- 2008-03-19 MA MA30764A patent/MA29791B1/fr unknown
- 2008-03-19 EC EC2008008296A patent/ECSP088296A/es unknown
- 2008-03-21 MY MYPI20080779A patent/MY143391A/en unknown
- 2008-04-16 NO NO20081844A patent/NO20081844L/no not_active Application Discontinuation
-
2010
- 2010-04-20 CY CY20101100359T patent/CY1110010T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2621805A1 (fr) | Composes therapeutiques | |
| AU2014223973B2 (en) | Amide compounds for the treatment of HIV | |
| AR084573A1 (es) | Quinoxalinas y aza-quinoxalinas como moduladores del receptor de crth | |
| AR126073A1 (es) | N-(hidroxialquil(hetero)aril)tetrahidrofuran carboxamidas como moduladores de canales de sodio | |
| HRP20250048T1 (hr) | Inhibitori tyk2 i njihova uporaba | |
| DE602004021959D1 (de) | Verbindungen mit agonistischer wirkung am beta2-adrenergen rezeptor und am muscarinischen rezeptor | |
| JP2023530319A (ja) | Ｎａｖ１．８阻害剤としての２－オキソ－オキサゾリジン－５－カルボキサミド | |
| CA2672373A1 (fr) | Derives de la nicotinamide en tant qu'inhibiteurs de h-pgds et leur utilisation dans le traitement de maladies liees aux prostaglandines d2 | |
| AR037008A1 (es) | El uso del antagonista del receptor nk-1 para la elaboracion de un medicamento para el tratamiento y/o prevencion de lesiones cerebrales, espinales o neuronales y una composicion farmaceutica que comprende uno o mas de dicho antagonista. | |
| PE20210414A1 (es) | Compuestos inhibidores de rip1 y metodos para preparar y usar los mismos | |
| HRP20230313T1 (hr) | Modulatori receptora cxcr7 piperidina | |
| HRP20210783T1 (hr) | Derivati karboksamida | |
| HRP20250282T1 (hr) | Fuzijski tri-ciklički spoj kao dvostruki inhibitor pde3/pde4 | |
| JP2016164163A (ja) | Ｈｉｖ複製の阻害剤 | |
| AR111808A1 (es) | Derivados de pirimidina como moduladores del receptor de pge2 | |
| AR065824A1 (es) | Sulfonilbenzamidas sustituidas con heterociclos bloqueantes de los canales de sodio,formulaciones farmaceuticas que las contienen y usos de las mismas en el tratamiento del dolor y particularmente del dolor cronico. | |
| AU2014234909A1 (en) | Acyclic cyanoethylpyrazolo pyridones as Janus kinase inhibitors | |
| ES2337581T3 (es) | Composicion para inhibir la proteasa del vih. | |
| RU2017145922A (ru) | МОДУЛЯТОРЫ ROR ГАММА(RORy) | |
| AR109650A1 (es) | Compuestos de heteroarilcarboxamida como inhibidores de ripk2 | |
| ATE487715T1 (de) | Triazolderivate als modulatoren von dopamin-d3- rezeptoren | |
| JP2018527354A5 (fr) | ||
| AR037770A1 (es) | Compuesto inhibidor de la integrasa del vih, composicion farmaceutica que lo comprende y uso del mismo para prepararla | |
| AR112794A1 (es) | Compuestos heteroaromáticos sustituidos con cicloolefinas y su uso en el tratamiento de enfermedades inducidas por mutaciones idh | |
| AR111826A1 (es) | Compuestos bicíclicos 5,6 fusionados y composiciones para el tratamiento de las enfermedades parasitarias |